AstraZeneca PLC (AZN)
201.33
-3.05
(-1.49%)
USD |
NYSE |
Apr 15, 16:00
201.60
+0.27
(+0.13%)
After-Hours: 20:00
AstraZeneca Research and Development Expense (Annual) : 13.84B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| GSK Plc | 8.171B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Mereo BioPharma Group Plc | 17.81M |
| Moderna, Inc. | 2.917B |
| Abivax SA | 200.62M |